Fabrizio Piazza
| University | Surgery and Translational Medicine - UNIMIB |
| fabrizio.piazza@unimib.it | |
| Website | https://sites.google.com/site/icabinternationalnetwork |
| Publications | http://scholar.google.it/citations?user=Kzv0tukAAAAJ |
News by: Fabrizio Piazza
- IV immunoglobulin for Alzheimer disease: No ARIA, no win?
- Disponibilità per Tesi Sperimentale in Biotecnologie/Biologia/Farmacologia: CHARACTERIZATION OF MONOMERIC-OLIGOMERIC- AND FIBRILLAR-ANTI-Aβ AUTOANTIBODIES IN CEREBRAL AMILOYD ANGIOPHATY-RELATED INFLAMMATION AND ALZHEIMER’S DISEASE PATIENTS
- HERE WE ARE!! The 50 most influential Alzheimer’s Disease research papers of the last five years.
- Immunotherapy Trials for Alzheimer’s Disease: Need for Prognostic Biomarkers?
- NeuroMI has been accepted to be part of the Centres of Excellence within the European Alzheimer’s Disease Consortium (EADC).
- 8TH CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD 2015), Barcelona, Spain
- Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): candidate biomarker for immunotherapy in Alzheimer’s disease and cerebral amyloid angiopathy.